CN1081035C - 抗疟疾新药复方萘酚喹 - Google Patents

抗疟疾新药复方萘酚喹 Download PDF

Info

Publication number
CN1081035C
CN1081035C CN97114291A CN97114291A CN1081035C CN 1081035 C CN1081035 C CN 1081035C CN 97114291 A CN97114291 A CN 97114291A CN 97114291 A CN97114291 A CN 97114291A CN 1081035 C CN1081035 C CN 1081035C
Authority
CN
China
Prior art keywords
medicine
naphtholquine
dihydroarteannuin
trimethoprim
phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97114291A
Other languages
English (en)
Chinese (zh)
Other versions
CN1191113A (zh
Inventor
李国桥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jianqiao Medicine Development Co., Ltd., Chongqing City
Original Assignee
Jianqiao Sci & Tech Dev Co Ltd Guangzhou City
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jianqiao Sci & Tech Dev Co Ltd Guangzhou City filed Critical Jianqiao Sci & Tech Dev Co Ltd Guangzhou City
Priority to CN97114291A priority Critical patent/CN1081035C/zh
Publication of CN1191113A publication Critical patent/CN1191113A/zh
Priority to ZA9810472A priority patent/ZA9810472B/xx
Priority to AU12227/99A priority patent/AU1222799A/en
Priority to PCT/CN1998/000274 priority patent/WO1999025351A1/zh
Priority to CO98067813A priority patent/CO4980890A1/es
Priority to PE1998001114A priority patent/PE134499A1/es
Application granted granted Critical
Publication of CN1081035C publication Critical patent/CN1081035C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CN97114291A 1997-11-18 1997-11-18 抗疟疾新药复方萘酚喹 Expired - Fee Related CN1081035C (zh)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN97114291A CN1081035C (zh) 1997-11-18 1997-11-18 抗疟疾新药复方萘酚喹
ZA9810472A ZA9810472B (en) 1997-11-18 1998-11-16 An antimalarial composition
AU12227/99A AU1222799A (en) 1997-11-18 1998-11-18 Antimalaria pharmaceutical compositions
PCT/CN1998/000274 WO1999025351A1 (fr) 1997-11-18 1998-11-18 Compositions pharmaceutiques antipaludiques
CO98067813A CO4980890A1 (es) 1997-11-18 1998-11-18 Una composicion antimalarica metodo para tratar la malaria
PE1998001114A PE134499A1 (es) 1997-11-18 1998-12-01 Composicion contra la malaria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97114291A CN1081035C (zh) 1997-11-18 1997-11-18 抗疟疾新药复方萘酚喹

Publications (2)

Publication Number Publication Date
CN1191113A CN1191113A (zh) 1998-08-26
CN1081035C true CN1081035C (zh) 2002-03-20

Family

ID=5172855

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97114291A Expired - Fee Related CN1081035C (zh) 1997-11-18 1997-11-18 抗疟疾新药复方萘酚喹

Country Status (6)

Country Link
CN (1) CN1081035C (xx)
AU (1) AU1222799A (xx)
CO (1) CO4980890A1 (xx)
PE (1) PE134499A1 (xx)
WO (1) WO1999025351A1 (xx)
ZA (1) ZA9810472B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1135974C (zh) * 2000-08-23 2004-01-28 重庆健桥医药开发有限公司 抗疟药新药复方双氢青蒿素
CN104666300B (zh) * 2014-07-04 2017-01-18 昆药集团股份有限公司 一种磷酸萘酚喹的用途
CN111265527B (zh) * 2020-03-05 2021-04-23 中国人民解放军军事科学院军事医学研究院 萘酚喹及其药学上可接受的盐在制备抗冠状病毒药物中的用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1041694A (zh) * 1988-10-07 1990-05-02 赫彻斯特股份公司 奎尼丁、青蒿素及其衍生物的抗疟组合物和治疗方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748333A1 (de) * 1977-10-28 1979-05-03 Hoechst Ag Mittel gegen malaria
US5219865A (en) * 1987-05-08 1993-06-15 Hoechst Aktiengesellschaft Pharmaceutical combination for the prophylaxis and therapy of malaria

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1041694A (zh) * 1988-10-07 1990-05-02 赫彻斯特股份公司 奎尼丁、青蒿素及其衍生物的抗疟组合物和治疗方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《中国医药工业杂志》，20(8) 1989.8.31 邓蓉仙，"我国近几年抗疟药研究新进展" *
《新编药物学》，第13版 1996.3.1 陈新谦，人民卫生出版社 *
《新编药物学》，第13版 1996.3.1 陈新谦，人民卫生出版社;《中国医药工业杂志》，20(8) 1989.8.31 邓蓉仙，"我国近几年抗疟药研究新进展" *

Also Published As

Publication number Publication date
AU1222799A (en) 1999-06-07
PE134499A1 (es) 2000-01-23
ZA9810472B (en) 1999-05-21
CO4980890A1 (es) 2000-11-27
WO1999025351A1 (fr) 1999-05-27
CN1191113A (zh) 1998-08-26

Similar Documents

Publication Publication Date Title
Liu et al. Traditional Chinese medicine (TCM): are polyphenols and saponins the key ingredients triggering biological activities?
CN107898782B (zh) 一种银杏二萜内酯组合物
EP2589382A1 (en) Pharmaceutical composition comprising levocarnitine and dobesilate
DE3883606T2 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
CN1081035C (zh) 抗疟疾新药复方萘酚喹
Widowati et al. Corilagin potential in inhibiting oxidative and inflammatory stress in LPS-induced murine macrophage cell lines (RAW 264.7)
CN110384725A (zh) 一种用于调整口腔菌群的中药组合及其活性提取物的制备
CN105213321B (zh) 一种青蒿素或其衍生物的药浴颗粒剂及其用途
EP0198172B1 (de) Pharmazeutische Zubereitung
CN1135974C (zh) 抗疟药新药复方双氢青蒿素
CN1528309A (zh) 复方青蒿素
DE68928415D1 (de) Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung
CA2454544A1 (en) Optic nerve protecting agents containing .alpha.1 receptor blocker as active ingredient
KR20020060168A (ko) α-리포산 또는 그 유도체의 투여에 의한 편두통의 치료
CN1092048C (zh) 复方哌喹片
MY118262A (en) Sulfonamide-substituted benzopyran derivatives, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them
DE3821392A1 (de) Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on (ebselen)
CN1309368C (zh) 治疗咳嗽的中药制剂
CN104147197A (zh) 一种治疗足癣的药物及其制备方法
CA2556758A1 (en) Use of beta-lapachone for treating or preventing cancer
CN1823815A (zh) 硫化钠静脉注射液在制备治疗脑梗死后遗症药剂中的应用
KR100259175B1 (ko) 엘-무스콘의 의약용도
CA2154907A1 (en) Use of eliprodil and enantiomers thereof for the preparation of medicines useful for preventing peripheral neuropathies induced by anticancer agents
CN116270873B (zh) 一种用于治疗皮肤癣菌感染的中药组合物
RU2077888C1 (ru) Способ лечения лучевой болезни у животных

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB02 Change of applicant information

Applicant after: Jianqiao Medicine Science & Technology Import & Export Co. Ltd.

Applicant before: Jianqiao Sci. & Tech. Dev. Co., Ltd., Guangzhou City

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: JIANQIAO SCI. + TECH. DEV. CO., LTD., GUANGZHOU CITY TO: JIANQIAO MEDICALTECHNOLOGY IMPORT + EXPORT CO., LTD., GUANGZHOU CITY

ASS Succession or assignment of patent right

Owner name: JIANQIAO MEDICINE SCIENCE DEVELOPMENT CO., LTD.,

Free format text: FORMER OWNER: JIANQIAO MEDICAL TECHNOLOGY IMPORT + EXPORT CO., LTD., GUANGZHOU CITY

Effective date: 20010707

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20010707

Applicant after: Jianqiao Sci & Tech. Dev. Co., Ltd., Guangzhou City

Applicant before: Jianqiao Medicine Science & Technology Import & Export Co. Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: CHONGQING JIANQIAO MEDICINAL DEVELOPMENT CO., LTD

Free format text: FORMER OWNER: JIANQIAO MEDICINE SCIENCE DEVELOPMENT CO., LTD., GUANGZHOU CITY

Effective date: 20080226

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20080226

Address after: Yubei Jiangbei District Three Village of Chongqing City No. 30 red Ding International Garden Block A room 1908 zip code: 400020

Patentee after: Jianqiao Medicine Development Co., Ltd., Chongqing City

Address before: Guangdong Province, Guangzhou City Guanghua Road 11 No. 21 Xiangkang trade building room 804 zip code: 510400

Patentee before: Jianqiao Sci & Tech. Dev. Co., Ltd., Guangzhou City

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20020320

Termination date: 20131118